Canaccord Genuity raises TransMedics Group target price to $120 from $95
TMDX•Canaccord Genuity raised its target price for TransMedics Group to $120 from $95.
Related News
Fluor Q3 revenue rises on record new awards
FLR•
Trump Media investors lose $2.2 billion while Trump holds $460 million stake
DJT•
Beam Global terminates ScoutDI acquisition agreement
BEEM•
Interface presents investor update highlighting 40.6% adjusted gross profit margin
TILE•
RBC raises JFrog target price to $121 from $118
FROG•